Amistad Pharmachem Private Limited - Charges

Every charge - open or closed - that lenders have registered against Amistad Pharmachem Private Limited, with the most recent activity at th…

2014-02-21 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
AP Amistad Pharmachem Private Limited
Open charges
1
3.00 cr
Closed charges
3
17.09 cr
Total
4
20.09 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 3 19.50 cr
2 Hdfc Bank Limited 1 58.58 Lakh
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100959807 Others 25 Jun 2024 - - 3.00 cr Open
100566764 Others 28 Apr 2022 - 18 Jun 2024 9.00 cr Closed
100419265 Hdfc Bank Limited 30 Jan 2021 - 19 Mar 2025 58.58 Lakh Closed
100402745 Others 28 Dec 2020 08 Jul 2022 18 Jun 2024 7.50 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Amistad Pharmachem Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Amistad Pharmachem Private Limited (CIN: U24100MH2014PTC253471). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Amistad Pharmachem Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.